TY - JOUR
T1 - Establishment of Minimal Clinically Important Improvement for Patient-Reported Symptoms to Define Recovery After Video-Assisted Thoracoscopic Surgery
AU - Xu, Wei
AU - Dai, Wei
AU - Gao, Zhen
AU - Wang, Xin Shelley
AU - Tang, Li
AU - Pu, Yang
AU - Yu, Qingsong
AU - Yu, Hongfan
AU - Nie, Yuxian
AU - Zhuang, Weitao
AU - Qiao, Guibin
AU - Cleeland, Charles S.
AU - Shi, Qiuling
N1 - Publisher Copyright:
© 2022, Society of Surgical Oncology.
PY - 2022/9
Y1 - 2022/9
N2 - Purpose: The aim of this study was to define a threshold of minimal clinically important improvement (MCII) for interpreting patient condition following video-assisted thoracoscopic surgery (VATS). Methods: Patients undergoing VATS were recruited for this multicenter, prospective, observational cohort study. Symptoms were measured using the MD Anderson Symptom Inventory–Lung Cancer Module perioperatively. To define MCIIs, we first identified index symptoms, defined as the most severe symptoms showing the largest reduction from day 1 post-surgery to discharge. MCIIs for each index symptom were then obtained via an anchor-based approach. Symptom recovery was defined as an MCII after post-surgery day 1. Cox regression models were used to identify risk factors for unrecovered index symptoms. Results: Using 366 patients, we identified pain and fatigue as index symptoms after VATS. MCII was defined as a 30% reduction in pain or fatigue. At discharge, 22.6% of patients had not recovered from pain and 22.4% had not recovered from fatigue. Cox models found that risk factors for unrecovered pain were Charlson Comorbidity Index score ≥1 (hazard ratio [HR] 1.36, 95% confidence interval [CI] 1.04–1.77; p = 0.02) and preoperative neoadjuvant therapy (HR 2.78, 95% CI 1.13–6.83; p = 0.02). Malignancy was a risk factor for unrecovered fatigue (HR 1.47, 95% CI 1.02–2.13; p = 0.04). Conclusion: Pain and fatigue can be used as index measures for symptom recovery in patients following VATS. A 30% MCII represented meaningful recovery after VATS and could identify patients who may need extensive care after discharge.
AB - Purpose: The aim of this study was to define a threshold of minimal clinically important improvement (MCII) for interpreting patient condition following video-assisted thoracoscopic surgery (VATS). Methods: Patients undergoing VATS were recruited for this multicenter, prospective, observational cohort study. Symptoms were measured using the MD Anderson Symptom Inventory–Lung Cancer Module perioperatively. To define MCIIs, we first identified index symptoms, defined as the most severe symptoms showing the largest reduction from day 1 post-surgery to discharge. MCIIs for each index symptom were then obtained via an anchor-based approach. Symptom recovery was defined as an MCII after post-surgery day 1. Cox regression models were used to identify risk factors for unrecovered index symptoms. Results: Using 366 patients, we identified pain and fatigue as index symptoms after VATS. MCII was defined as a 30% reduction in pain or fatigue. At discharge, 22.6% of patients had not recovered from pain and 22.4% had not recovered from fatigue. Cox models found that risk factors for unrecovered pain were Charlson Comorbidity Index score ≥1 (hazard ratio [HR] 1.36, 95% confidence interval [CI] 1.04–1.77; p = 0.02) and preoperative neoadjuvant therapy (HR 2.78, 95% CI 1.13–6.83; p = 0.02). Malignancy was a risk factor for unrecovered fatigue (HR 1.47, 95% CI 1.02–2.13; p = 0.04). Conclusion: Pain and fatigue can be used as index measures for symptom recovery in patients following VATS. A 30% MCII represented meaningful recovery after VATS and could identify patients who may need extensive care after discharge.
UR - http://www.scopus.com/inward/record.url?scp=85127569073&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127569073&partnerID=8YFLogxK
U2 - 10.1245/s10434-022-11629-7
DO - 10.1245/s10434-022-11629-7
M3 - Article
C2 - 35368219
AN - SCOPUS:85127569073
SN - 1068-9265
VL - 29
SP - 5593
EP - 5604
JO - Annals of surgical oncology
JF - Annals of surgical oncology
IS - 9
ER -